# Psilocybin for Hospitalized Patients with Treatment-resistant Depression

> **NCT06378229** · PHASE2 · RECRUITING · sponsor: **University Hospital, Ghent** · enrollment: 100 (estimated)

## Conditions studied

- Treatment Resistant Depression

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT06378229
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-21
- **Primary completion:** 2026-03
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06378229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06378229, "Psilocybin for Hospitalized Patients with Treatment-resistant Depression". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06378229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*